Page last updated: 2024-10-18

dihydroxyphenylalanine and Albinism, Oculocutaneous

dihydroxyphenylalanine has been researched along with Albinism, Oculocutaneous in 8 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Albinism, Oculocutaneous: Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types.

Research Excerpts

ExcerptRelevanceReference
" Tyrosine hydroxylase activity determined with cell lysates (in vitro), entire fixed cells (postfixation), or intact living cells (in situ), and 3,4-dihydroxyphenylalanine oxidase assayed spectrophotometrically or by 3,4-dihydroxyphenylalanine staining on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, demonstrated the following results: 1) The in situ assay displayed reduced tyrosine hydroxylase activity in all three tyrosinase-positive oculocutaneous albino (OCA) lines except for Chediak-Higashi Syndrome melanocytes, which displayed normal activity; 2) The in vitro assay had comparable activity of tyrosinase-positive OCA melanocytes as controls, except for one tyrosinase-positive OCA cell line, which demonstrated increased activity; 3) The postfixation assay, compared with the in situ assay, had elevated activity (ie."3.69Distinguishing between the catalytic potential and apparent expression of tyrosinase activities. ( Boissy, RE; Zhao, H, 1994)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halaban, R1
Cheng, E1
Hebert, DN1
Shimizu, H1
Ishiko, A1
Kikuchi, A1
Akiyama, M1
Suzumori, K1
Nishikawa, T1
Zhao, H2
Boissy, RE2
Oetting, WS2
Austin, LM1
Wildenberg, SC1
Boissy, YL1
Zhao, Y1
Sturm, RA1
Hearing, VJ2
King, RA2
Nordlund, JJ1
Schallreuter, KU1
Tsukamoto, K1
Jiménez, M1
Gershoni-Baruch, R1
Benderly, A1
Brandes, JM1
Gilhar, A1

Reviews

2 reviews available for dihydroxyphenylalanine and Albinism, Oculocutaneous

ArticleYear
A review of recent advances on the regulation of pigmentation in the human epidermis.
    Cellular and molecular biology (Noisy-le-Grand, France), 1999, Volume: 45, Issue:7

    Topics: Albinism, Oculocutaneous; alpha-MSH; Biopterins; Dihydroxyphenylalanine; Enzyme Activation; Epidermi

1999
The nature of tyrosinase isozymes.
    Pigment cell research, 1992, Volume: Suppl 2

    Topics: Albinism, Oculocutaneous; Animals; Catalase; Dihydroxyphenylalanine; Genes; Glycoproteins; Isoenzyme

1992

Other Studies

6 other studies available for dihydroxyphenylalanine and Albinism, Oculocutaneous

ArticleYear
Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:2

    Topics: Albinism, Oculocutaneous; Animals; Cells, Cultured; Dihydroxyphenylalanine; Enzyme Stability; Glycos

2002
Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by an electron microscopic dopa reaction test of fetal skin.
    Prenatal diagnosis, 1994, Volume: 14, Issue:6

    Topics: Adult; Albinism, Oculocutaneous; Child; Dihydroxyphenylalanine; Female; Humans; Male; Melanocytes; M

1994
Distinguishing between the catalytic potential and apparent expression of tyrosinase activities.
    The American journal of the medical sciences, 1994, Volume: 308, Issue:6

    Topics: Albinism, Oculocutaneous; Catalysis; Cell Line; Cells, Cultured; Chediak-Higashi Syndrome; Dihydroxy

1994
Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    American journal of human genetics, 1996, Volume: 58, Issue:6

    Topics: Albinism, Oculocutaneous; Base Sequence; Cells, Cultured; Dihydroxyphenylalanine; Diseases in Twins;

1996
Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Human genetics, 1992, Volume: 90, Issue:3

    Topics: Albinism, Oculocutaneous; Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Cells, Culture

1992
Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism.
    Journal of the American Academy of Dermatology, 1991, Volume: 24, Issue:2 Pt 1

    Topics: Albinism, Oculocutaneous; Dihydroxyphenylalanine; Fetal Diseases; Fetus; Gestational Age; Hair; Huma

1991